336 related articles for article (PubMed ID: 29471670)
21. Restriction spectrum imaging predicts response to bevacizumab in patients with high-grade glioma.
McDonald CR; Delfanti RL; Krishnan AP; Leyden KM; Hattangadi-Gluth JA; Seibert TM; Karunamuni R; Elbe P; Kuperman JM; Bartsch H; Piccioni DE; White NS; Dale AM; Farid N
Neuro Oncol; 2016 Nov; 18(11):1579-1590. PubMed ID: 27106406
[TBL] [Abstract][Full Text] [Related]
22. Misleading early blood volume changes obtained using ferumoxytol-based magnetic resonance imaging perfusion in high grade glial neoplasms treated with bevacizumab.
Netto JP; Schwartz D; Varallyay C; Fu R; Hamilton B; Neuwelt EA
Fluids Barriers CNS; 2016 Dec; 13(1):23. PubMed ID: 27998280
[TBL] [Abstract][Full Text] [Related]
23. Differentiation of high-grade and low-grade diffuse gliomas by intravoxel incoherent motion MR imaging.
Togao O; Hiwatashi A; Yamashita K; Kikuchi K; Mizoguchi M; Yoshimoto K; Suzuki SO; Iwaki T; Obara M; Van Cauteren M; Honda H
Neuro Oncol; 2016 Jan; 18(1):132-41. PubMed ID: 26243792
[TBL] [Abstract][Full Text] [Related]
24. Comparison of accuracy of intravoxel incoherent motion and apparent diffusion coefficient techniques for predicting malignancy of head and neck tumors using half-Fourier single-shot turbo spin-echo diffusion-weighted imaging.
Sakamoto J; Imaizumi A; Sasaki Y; Kamio T; Wakoh M; Otonari-Yamamoto M; Sano T
Magn Reson Imaging; 2014 Sep; 32(7):860-6. PubMed ID: 24832359
[TBL] [Abstract][Full Text] [Related]
25. The Development of Reduced Diffusion Following Bevacizumab Therapy Identifies Regions of Recurrent Disease in Patients with High-grade Glioma.
Barajas RF; Butowski NA; Phillips JJ; Aghi MK; Berger MS; Chang SM; Cha S
Acad Radiol; 2016 Sep; 23(9):1073-82. PubMed ID: 27443507
[TBL] [Abstract][Full Text] [Related]
26. Assessment of glioma response to radiotherapy using 3D pulsed-continuous arterial spin labeling and 3D segmented volume.
Wang P; Li J; Diao Q; Lin Y; Zhang J; Li L; Yang G; Fang X; Li X; Chen Y; Zheng L; Lu G
Eur J Radiol; 2016 Nov; 85(11):1987-1992. PubMed ID: 27776650
[TBL] [Abstract][Full Text] [Related]
27. IVIM perfusion fraction is prognostic for survival in brain glioma.
Federau C; Cerny M; Roux M; Mosimann PJ; Maeder P; Meuli R; Wintermark M
Clin Neuroradiol; 2017 Dec; 27(4):485-492. PubMed ID: 27116215
[TBL] [Abstract][Full Text] [Related]
28. Surgery for Recurrent High-Grade Glioma After Treatment with Bevacizumab.
Blumenthal DT; Kanner AA; Aizenstein O; Cagnano E; Greenberg A; Hershkovitz D; Ram Z; Bokstein F
World Neurosurg; 2018 Feb; 110():e727-e737. PubMed ID: 29183864
[TBL] [Abstract][Full Text] [Related]
29. Comparative evaluation of 3-dimensional pseudocontinuous arterial spin labeling with dynamic contrast-enhanced perfusion magnetic resonance imaging in grading of human glioma.
Roy B; Awasthi R; Bindal A; Sahoo P; Kumar R; Behari S; Ojha BK; Husain N; Pandey CM; Rathore RK; Gupta RK
J Comput Assist Tomogr; 2013; 37(3):321-6. PubMed ID: 23673999
[TBL] [Abstract][Full Text] [Related]
30. Intravoxel incoherent motion diffusion-weighted imaging of hepatocellular carcinoma: Is there a correlation with flow and perfusion metrics obtained with dynamic contrast-enhanced MRI?
Hectors SJ; Wagner M; Besa C; Bane O; Dyvorne HA; Fiel MI; Zhu H; Donovan M; Taouli B
J Magn Reson Imaging; 2016 Oct; 44(4):856-64. PubMed ID: 26919327
[TBL] [Abstract][Full Text] [Related]
31. Comparative study of pulsed-continuous arterial spin labeling and dynamic susceptibility contrast imaging by histogram analysis in evaluation of glial tumors.
Arisawa A; Watanabe Y; Tanaka H; Takahashi H; Matsuo C; Fujiwara T; Fujiwara M; Fujimoto Y; Tomiyama N
Neuroradiology; 2018 Jun; 60(6):599-608. PubMed ID: 29705876
[TBL] [Abstract][Full Text] [Related]
32. Change in 18F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment.
Yamaguchi S; Hirata K; Toyonaga T; Kobayashi K; Ishi Y; Motegi H; Kobayashi H; Shiga T; Tamaki N; Terasaka S; Houkin K
PLoS One; 2016; 11(12):e0167917. PubMed ID: 27936194
[TBL] [Abstract][Full Text] [Related]
33. [Application value of whole brain 3D artery spin labeling in diagnosis of intracranial tumors].
Zhao QQ; Yang QX; Xu GX; Lü YC; Rong DL; Liu L; Zhang R
Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1801-1804. PubMed ID: 28648002
[No Abstract] [Full Text] [Related]
34. Correlative assessment of tumor microcirculation using contrast-enhanced perfusion MRI and intravoxel incoherent motion diffusion-weighted MRI: is there a link between them?
Bisdas S; Braun C; Skardelly M; Schittenhelm J; Teo TH; Thng CH; Klose U; Koh TS
NMR Biomed; 2014 Oct; 27(10):1184-91. PubMed ID: 25088433
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the apparent diffusion coefficient in patients with recurrent glioblastoma under treatment with bevacizumab with radiographic pseudoresponse.
Auer TA; Breit HC; Marini F; Renovanz M; Ringel F; Sommer CJ; Brockmann MA; Tanyildizi Y
J Neuroradiol; 2019 Feb; 46(1):36-43. PubMed ID: 29733920
[TBL] [Abstract][Full Text] [Related]
36. Intravoxel incoherent motion diffusion-weighted imaging in stroke patients: initial clinical experience.
Yao Y; Zhang S; Tang X; Zhang S; Shi J; Zhu W; Zhu W
Clin Radiol; 2016 Sep; 71(9):938.e11-6. PubMed ID: 27210244
[TBL] [Abstract][Full Text] [Related]
37. Diffusion heterogeneity and vascular perfusion in tumor and peritumoral areas for prediction of overall survival in patients with high-grade glioma.
Qiu J; Zhu M; Chen CY; Luo Y; Wen J
Magn Reson Imaging; 2023 Dec; 104():23-28. PubMed ID: 37734575
[TBL] [Abstract][Full Text] [Related]
38. Dynamic contrast-enhanced MRI may be helpful to predict response and prognosis after bevacizumab treatment in patients with recurrent high-grade glioma: comparison with diffusion tensor and dynamic susceptibility contrast imaging.
Park YW; Ahn SS; Moon JH; Kim EH; Kang SG; Chang JH; Kim SH; Lee SK
Neuroradiology; 2021 Nov; 63(11):1811-1822. PubMed ID: 33755766
[TBL] [Abstract][Full Text] [Related]
39. Perfusion MRI as the predictive/prognostic and pharmacodynamic biomarkers in recurrent malignant glioma treated with bevacizumab: a systematic review and a time-to-event meta-analysis.
Choi SH; Jung SC; Kim KW; Lee JY; Choi Y; Park SH; Kim HS
J Neurooncol; 2016 Jun; 128(2):185-94. PubMed ID: 27108275
[TBL] [Abstract][Full Text] [Related]
40. Use of diffusion-weighted magnetic resonance imaging to distinguish between lung cancer and focal inflammatory lesions: a comparison of intravoxel incoherent motion derived parameters and apparent diffusion coefficient.
Deng Y; Li X; Lei Y; Liang C; Liu Z
Acta Radiol; 2016 Nov; 57(11):1310-1317. PubMed ID: 25972370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
